ATRC251017P00022500 Option on AtriCure
ATRC Stock | USD 35.13 3.40 10.72% |
ATRC251017P00022500 is a PUT option contract on AtriCure's common stock with a strick price of 22.5 expiring on 2025-10-17. The contract was not traded in recent days and, as of today, has 79 days remaining before the expiration. The option is currently trading at an ask price of $4.8. The implied volatility as of the 30th of July is 79.0.
A put option written on AtriCure becomes more valuable as the price of AtriCure drops. Conversely, AtriCure's put option loses its value as AtriCure Stock rises.
Rule 16 of 2025-10-17 Option Contract
The options market is anticipating that AtriCure will have an average daily up or down price movement of about 0.0756% per day over the life of the option. With AtriCure trading at USD 35.13, that is roughly USD 0.0266. If you think that the market is fully understating AtriCure's daily price movement you should consider buying AtriCure options at that current volatility level of 1.21%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Put Option on AtriCure
An 'Out of The Money' option on AtriCure has a strike price that AtriCure Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for AtriCure's 'Out of The Money' options include buying the options if you expect a big move in AtriCure's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Put Contract Name | ATRC251017P00022500 |
Expires On | 2025-10-17 |
Days Before Expriration | 79 |
Vega | 0.039365 |
Gamma | 0.014771 |
Theoretical Value | 2.4 |
Open Interest | 1 |
Strike Price | 22.5 |
Current Price Spread | 0.0 | 4.8 |
Rule 16 Daily Up or Down | USD 0.0266 |
AtriCure short PUT Option Greeks
AtriCure's Option Greeks for the contract ending on 2025-10-17 at a strike price of 22.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to AtriCure's option greeks, its implied volatility helps estimate the risk of AtriCure stock implied by the prices of the options on AtriCure's stock.
Delta | -0.182884 | |
Gamma | 0.014771 | |
Theta | -0.028899 | |
Vega | 0.039365 | |
Rho | -0.015991 |
AtriCure long PUT Option Payoff at expiration
Put options written on AtriCure grant holders of the option the right to sell a specified amount of AtriCure at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of AtriCure Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on AtriCure is like buying insurance aginst AtriCure's downside shift.
Profit |
AtriCure Price At Expiration |
AtriCure short PUT Option Payoff at expiration
By selling AtriCure's put option, the investors signal their bearish sentiment. A short position in a put option written on AtriCure will generally make money when the underlying price is above the strike price. Therefore AtriCure's put payoff at expiration depends on where the AtriCure Stock price is relative to the put option strike price. The breakeven price of 20.1 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to AtriCure's price. Finally, at the strike price of 22.5, the payoff chart is constant and positive.
Profit |
AtriCure Price At Expiration |
AtriCure Available Put Options
AtriCure's option chain is a display of a range of information that helps investors for ways to trade options on AtriCure. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for AtriCure. It also shows strike prices and maturity days for a AtriCure against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Put | ATRC251017P00060000 | 0 | 60.0 | 25.6 - 30.5 | 25.6 | In |
Put | ATRC251017P00055000 | 0 | 55.0 | 21.0 - 25.5 | 25.3 | In |
Put | ATRC251017P00050000 | 0 | 50.0 | 16.0 - 20.9 | 16.0 | In |
Put | ATRC251017P00045000 | 0 | 45.0 | 11.0 - 15.9 | 11.0 | In |
Put | ATRC251017P00040000 | 0 | 40.0 | 6.5 - 10.8 | 6.5 | In |
Put | ATRC251017P00035000 | 1 | 35.0 | 2.5 - 7.0 | 2.5 | In |
Put | ATRC251017P00030000 | 1 | 30.0 | 0.0 - 4.8 | 5.6 | Out |
Put | ATRC251017P00025000 | 2 | 25.0 | 0.0 - 4.8 | 0.8 | Out |
Put | ATRC251017P00022500 | 1 | 22.5 | 0.0 - 4.8 | 4.8 | Out |
Put | ATRC251017P00020000 | 0 | 20.0 | 0.0 - 4.8 | 4.8 | |
Put | ATRC251017P00015000 | 2 | 15.0 | 0.0 - 4.8 | 4.8 | Out |
AtriCure Corporate Management
Deborah Yount | Chief Officer | Profile | |
Tonya SPHR | VP HR | Profile | |
Vinayak Doraiswamy | Chief Officer | Profile | |
JD CCEP | Chief Officer | Profile | |
Salvatore JD | Chief Officer | Profile | |
CCEP CCEP | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Revenue Per Share | Quarterly Revenue Growth 0.136 | Return On Assets | Return On Equity |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.